Cinedigm (CIDM) Stock Forecast, Price & News

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cinedigm in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" CIDM shares.
View CIDM analyst ratings or view top-rated stocks.

1 brokers have issued 12 month price targets for Cinedigm's stock. Their CIDM share price forecasts range from $5.00 to $5.00. On average, they anticipate the company's share price to reach $5.00 in the next year. This suggests a possible upside of 1,597.8% from the stock's current price.
View analysts price targets for CIDM or view top-rated stocks among Wall Street analysts.

Cinedigm's stock was trading at $0.3877 at the beginning of 2023. Since then, CIDM shares have decreased by 24.0% and is now trading at $0.2945.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Monday, June 26th 2023.
View our CIDM earnings forecast.

Cinedigm Corp. (NASDAQ:CIDM) released its quarterly earnings data on Thursday, September, 9th. The business services provider reported $0.03 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.03) by $0.06. The business services provider earned $15.02 million during the quarter. Cinedigm had a negative net margin of 13.30% and a negative trailing twelve-month return on equity of 24.40%.

Cinedigm shares reverse split before market open on Tuesday, May 10th 2016. The 1-10 reverse split was announced on Monday, May 9th 2016. The number of shares owned by shareholders was adjusted after the market closes on Monday, May 9th 2016. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

21 employees have rated Cinedigm Chief Executive Officer Chris McGurk on Glassdoor.com. Chris McGurk has an approval rating of 58% among the company's employees. This puts Chris McGurk in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. 41.0% of employees surveyed would recommend working at Cinedigm to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cinedigm investors own include Genius Brands International (GNUS), Acasti Pharma (ACST), Workhorse Group (WKHS), NIO (NIO), Novavax (NVAX), Abraxas Petroleum (AXAS), Evofem Biosciences (EVFM), Remark (MARK), Sorrento Therapeutics (SRNE) and Tesla (TSLA).

Cinedigm trades on the NASDAQ under the ticker symbol "CIDM."

Cinedigm's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Dimensional Fund Advisors LP (0.12%) and Virtu Financial LLC (0.04%). Insiders that own company stock include Bison Entertainment Investment and John K Canning.
View institutional ownership trends.

Shares of CIDM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CIDM stock can currently be purchased for approximately $0.29.

Cinedigm (NASDAQ:CIDM) has a market capitalization of $55.04 million and generates $56.05 million in revenue each year. The business services provider earns $2.21 million in net income (profit) each year or ($0.05) on an earnings per share basis.

Cinedigm's mailing address is 237 WEST 35TH STREET SUITE 605, NEW YORK NY, 10001. The official website for the company is www.cinedigm.com. The business services provider can be reached via phone at (212) 206-8600, via email at jcalcaterra@cinedigm.com, or via fax at 212-598-4898.